SG3 Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-225,000
Closed -$18M 320
2022
Q2
$18M Hold
225,000
2.12% 8
2022
Q1
$17.1M Buy
+225,000
New +$17.8M 0.48% 36
2021
Q2
Sell
-5,800
Closed -$457K 1074
2021
Q1
$457K Sell
5,800
-94,200
-94% -$7.38M 0.01% 800
2020
Q4
$8.55M Buy
+100,000
New +$8.27M 0.16% 125
2019
Q4
Sell
-2,400
Closed -$176K 273
2019
Q3
$176K Sell
2,400
-1,400
-37% -$102K 0.02% 245
2019
Q2
$272K Buy
+3,800
New +$270K 0.03% 268
2017
Q3
Sell
-6,500
Closed -$482K 182
2017
Q2
$482K Buy
+6,500
New +$483K 0.12% 141

Other funds holding CL

SG3 Management's CL Position: Q1 2022 in Review

SG3 Management sold out of Colgate-Palmolive (CL) in Q1 2022, closing a stake of 124,000 shares — an estimated $9.82M sold.

SG3 Management first reported a position in CL in Q2 2017 and held it in 3 quarters. The position peaked at $10.6M in Q4 2021. 1,632 funds tracked by Wall St. Rank hold CL as of Q1 2022.

  • SG3 Management reported no remaining Colgate-Palmolive position as of Q1 2022 after selling out during the quarter.
  • SG3 Management sold 124,000 Colgate-Palmolive shares in Q1 2022, an estimated $9.82M.
  • SG3 Management first reported a position in Colgate-Palmolive in Q2 2017 and held it in 3 quarters.
  • SG3 Management's Colgate-Palmolive position peaked at $10.6M in Q4 2021.
  • 1,632 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2022.

Based on SG3 Management's 13F filing for Q1 2022, filed 16 May 2022.